UniProtKB/SwissProt variant VAR

Variant information

Variant position:

265

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LB/B

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glutamine (Q) at position 265 (R265Q, p.Arg265Gln).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (Q)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Polymorphism:

Variation of PPARGC1B may contribute to the pathogenesis of obesity, with a widespread Ala-203 allele being a risk factor for the development of this common disorders.

Additional information on the polymorphism described.

Other resources:

Links to websites of interest for the variant.

Variant rs45520937 [ dbSNP | Ensembl ]

Sequence information

Variant position:

265

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

1023

The length of the canonical sequence.

Location on the sequence:

KEDKEPGEDCPSPQPAPASP R DSLALGRADPGAPVSQEDMQ

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KE-DKEPGEDCPSPQPAPASPRDSLALGRADP-GAPVSQEDMQ

Mouse                         KEEEEEVGEDCPSPWPTPASPQDSLAQDTASPDSAQPPEED

Rat                           KE-DEEVGEDCPSPWPAPASPQDSLGQDTANPNSAQVPKDD

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1023	Peroxisome proliferator-activated receptor gamma coactivator 1-beta
Region	237 – 278	Disordered

Literature citations

Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo.
Meirhaeghe A.; Crowley V.; Lenaghan C.; Lelliott C.; Green K.; Stewart A.; Hart K.; Schinner S.; Sethi J.K.; Yeo G.; Brand M.D.; Cortright R.N.; O'Rahilly S.; Montague C.; Vidal-Puig A.J.;
Biochem. J. 373:155-165(2003)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4); TISSUE SPECIFICITY; FUNCTION; VARIANT GLN-265;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q86YN6: Variant p.Arg265Gln